Isoflavonoids and Epigenetic Modulation: Therapeutic Insights for Cancer Treatment
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202503446 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Eduardo de Moraes E Sousa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Northeast Biotechnology Network-RENORBIO, Recife, Brazil. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Neoplasms, Isoflavones, Flavonoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian National Council for Scientific and Technological Development-CNPq, National Program for Oncological Care, Brazilian Studies and Projects Funding Agency (FINEP)/MCTI/FNDCT.
Abstract (Originalsprache)
Isolavonoides represent the second largest subgroup of flavonoids and have an influence on critical molecular pathways and restore cellular homeostasis, through the reprogramming of epigenetic regulatory mechanisms. This feature indicates a crucial therapeutic potential that could be better explored to attend cancer treatment. Isoflavonoids, acting as epigenetic modulators, could contribute to the development of new therapeutic approaches in cancer, especially in onco‐hematological diseases. Pterocarpans are a subgroup of isoflavonoids that have been extensively studied for their biological properties. The molecule (+)‐2,3,9‐trimethoxypterocarpan demonstrates high gastrointestinal (GI) absorption and the ability to cross the blood–brain barrier (BBB) in silico without violating Lipinski's rule, making it a desirable candidate in leukemia treatment. The synthesis of this molecule dates back more than a decade. In silico models, such as SwissADME, corroborate the notion of good intestinal absorption and the ability to cross the BBB. Also, it is suggested that P‐glycoprotein is a substrate, which is related to its potential for active efflux from both the BBB and GI. This review highlights the biological mechanisms of this class of natural products from a translational perspective, emphasizing their chemical properties and epigenetic biological activities, which offer new therapeutic perspectives, particularly in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northeast Biotechnology Network-RENORBIO, Recife, Brazil.
- Drug Research and Development Center, Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza, Brazil.
- Ceará Cancer Institute-ICC/Rodolfo Teófilo Faculty-F, Fortaleza, Brazil.
- Department of Translational Medicine, Federal University of Ceará, Fortaleza, Brazil.
- Núcleo De Biologia Experimental (Nubex), Fortaleza, Brazil.
- Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
ORCID-Profile: Eduardo de Moraes E Sousa, Maria Claudia Dos Santos Luciano, Gabriel Caetano de Souza, Maria Francilene Souza Silva, Fátima de Cássia Evangelista de Oliveira, Sarah Sant'Anna Maranhão, Felipe Vasconcelos, Cristiana Libardi Miranda Furtado, Claudia do Ó Pessoa
Förderung
- Brazilian National Council for Scientific and Technological Development-CNPq
- National Program for Oncological Care
- Brazilian Studies and Projects Funding Agency (FINEP)/MCTI/FNDCT
- Innovation Brazil-Health-ICTs
- National Institutes of Science and Technology-INCT
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
Zitieren
APA
de Moraes E Sousa, E., Luciano, M. C. D. S., de Souza, G. C., Silva, M. F. S., de Oliveira, F. C. E., Maranhão, S. S., Vasconcelos, F., Furtado, C. L. M., & do Ó Pessoa, C. (2026). Isoflavonoids and Epigenetic Modulation: Therapeutic Insights for Cancer Treatment. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202503446
Vancouver
de Moraes E Sousa E, Luciano MCDS, de Souza GC, Silva MFS, de Oliveira FCE, Maranhão SS, et al. Isoflavonoids and Epigenetic Modulation: Therapeutic Insights for Cancer Treatment. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202503446
BibTeX
@article{deMoraesESousa2026,
author = {de Moraes E Sousa, Eduardo and Luciano, Maria Claudia Dos Santos and de Souza, Gabriel Caetano and Silva, Maria Francilene Souza and de Oliveira, Fátima de Cássia Evangelista and Maranhão, Sarah Sant'Anna and Vasconcelos, Felipe and Furtado, Cristiana Libardi Miranda and do Ó Pessoa, Claudia},
title = {Isoflavonoids and Epigenetic Modulation: Therapeutic Insights for Cancer Treatment},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202503446}
}
EUVIMED